Medical Developments International | MVP - Eigenkapital Und Reserven

Aktienkurs
0.43
Täglich Wechseln
-0.01 -2.27%
Monatlich
11.69%
Jährlich
-26.50%
Q2 Prognose
0.43




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 2.15M 650K 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Clinuvel Pharmaceuticals AUD 249.02M 8.21M 2025-12
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Genetic Signatures AUD 44.09M 6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Medical Developments International AUD 54.77M 335K 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organon & Co USD 903M 151M 2026-03
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Starpharma Holdings AUD 21.48M 2.48M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03